Comparative susceptibilities of various AIDS-associated and human urogenital tract mycoplasmas and strains of Mycoplasma pneumoniae to 10 classes of antimicrobial agent in vitro

Journal of Medical Microbiology

Volumn 47, Issue 12, 1998, Pages 1115-1122

  Hannan, P C T ^a  

^a Mycoplasma Experience Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; AZITHROMYCIN; BETA LACTAM; CHLORAMPHENICOL; CLINDAMYCIN; DITERPENE; LINCOSAMIDE; MACROLIDE; PSEUDOMONIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN; STREPTOMYCIN; TETRACYCLINE DERIVATIVE; TIAMULIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBIOTIC SENSITIVITY; ARTICLE; HUMAN; LABORATORY TEST; MINIMUM INHIBITORY CONCENTRATION; MYCOPLASMA; MYCOPLASMA GENITALIUM; MYCOPLASMA HOMINIS; MYCOPLASMA PNEUMONIAE; PRIORITY JOURNAL; UROGENITAL TRACT DISEASE;

EID: 0031725507     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/00222615-47-12-1115     Document Type: Article

References (39)

1. Lo SC, Shih JW-K, Yang N-Y, Ou C-Y, Wang RY-H. A novel virus-like infectious agent in patients with AIDS. Am J Trop Med Hyg 1989; 40: 213-226.
2. Montagnier L, Berneman D, Guétard D et al. Inhibition de l'infectionsité de souches prototypes du VIH par des anticorps dirigés contre une séquence peptidique de mycoplasme. CR Acad Sci 1990; Paris t 311, Série 111: 425-430.
3. Dawson MS, Hayes MM, Wang RY-H, Armstrong D, Kundsin RB, Lo SC. Detection and isolation of Mycoplasma fermentans from urine of human immunodeficiency virus type-1 infected patients. Arch Pathol Lab Med 1993; 117: 511-514.
4. Lo S-C, Hayes MM, Wang RY-H, Pierce PF, Kotani H, Shih JW-K. Newly discovered mycoplasma isolated from patients infected with HIV. Lancet 1991; 338: 1415-1418.
5. Grau O, Kovacic R, Griffais R, Montagnier L. Development of a selective and sensitive polymerase chain reaction assay for the detection of Mycoplasma pirum. FEMS Microbiol Lett 1993; 106: 327-334.
6. De Barbeyrac B, Dupon M, Grau O et al. Mycoplasmas in patients infected with HIV-1. IOM Letters vol. 4. 11th International Congress of the International Organisation of Mycoplasmology (IOM), Orlando, FL, USA. July 14-19, 1996: 69.
7. Baseman JB, Dallo SF, Tully JG, Rose DL. Isolation and characterization of Mycoplasma genitalium strains from the human respiratory tract. J Clin Microbiol 1988; 26: 2266-2269.
8. Renaudin H, Tully JG. Bébéar C. In vitro susceptibilities of Mycoplasma genitalium to antibiotics. Antimicrob Agents Chemother 1992; 36: 870-872.
9. Lind K, Lindhardt BØ, Schütten HJ, Blom J, Christiansen C. Serological cross-reactions between Mycoplasma genitalium and Mycoplasma pneumoniae. J Clin Microbiol 1984; 20: 1036-1043.
10. Hayes MM, Foo H-H, Kotani H, Wear DJ, Lo S-C. In vitro antibiotic susceptibility testing of different strains of Mycoplasma fermentans isolated from a variety of sources. Antimicrob Agents Chemother 1993; 37: 2500-2503.
11. Hannan PCT. Antibiotic susceptibility of Mycoplasma fermentans strains from various sources and the development of resistance to aminoglycosides in vitro. J Med Microbiol 1995; 42: 421-428.
12. Hayes MM, Foo H-H, Timenetsky J, Lo S-C. In vitro antibiotic sensitivity testing of clinical isolates of Mycoplasma penetrans from patients with AIDS. Antimicrob Agents Chemother 1995; 39: 1386-1387.
13. Jao RL, Finland M. Susceptibility of Mycoplasma pneumoniae to 21 antibiotics in vitro. Am J Med Sci 1967; 253: 639-650
14. Stewart SM, Burnet ME, Young JE. In-vitro sensitivity of strains of Mycoplasmas from human sources to antibiotics and to sodium aurothiomalate and tylosin tartrate. J Med Microbiol 1969; 2: 287-292.
15. Braun P, Klein JO, Kass EH. Susceptibility of genital mycoplasmas to antimicrobial agents. Appl Microbiol 1970; 19: 62-70.
16. Quentin C, Cantet P, Renaudin H, Bébéar C. [Antibiotic sensitivity of mycoplasmas pathogenic for man.] Sensibilité aux antibiotiques des mycoplasmes pathogenes pour l'homme. Pathol Biol 1985; 33: 205-212.
17. Waites KB, Cassell GH, Canupp KC, Fernandes PB. In vitro susceptibilities of mycoplasmas and ureaplasmas to new macrolides and aryl-fluoroquinolones. Antimicrob Agents chemother 1988; 32: 1500-1502.
18. Kenny GE, Hooton TM, Roberts MC, Cartwright FD, Hoyt J. Susceptibilities of genital mycoplasmas to the newer quinolones as determined by the agar dilution method. Antimicrob Agents Chemother 1989; 33: 103-107.
19. Kenny GE, Cartwright FD. Susceptibilities of Mycoplasma homonis and Ureaplasma urealyticum to two new qiunolines, Sparfloxacin and WIN 57273. Antimicrob Agents Chemother 1991; 35: 1515-1516.
20. Kenny GE, Cartwright FD. Susceptibilities of Mycoplasma homonis, Mycoplasma pneumoniae, and Ureaplasma urealyticum to new glycyclines in comparison with those to older tetracyclines. Antimicrob Agents Chemother 1994; 38: 2628-2632.
21. Kenny GE, Cartwright FD. Susceptibility of Mycoplasma pneumoniae to several new quinolones, tetracycline, and erythromycin. Antimicrob Agents Chemother 1991; 35: 587-589.
22. Waites KB, Dully LB, Schmid T, Crabb D, Pate MS, Cassell GH. In vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to Sparfloxacin and PD 127391. Antimicrob Agents Chemother 1991; 35: 1181-1185.
23. Poulin SA, Perkins RE, Kundsin RB. Antibiotic susceptibilites of AIDS-associated Mycoplasmas. J Clin Microbiol 1994; 32: 1101-1103.
24. Furneri PM, Bisignano G, Cerniglia G, Nicoletti G, Cesana M, Tempera G. In vitro antimycoplasmal activities of Rufloxacin and its metabolile MF 922. Antimicrob Agents Chemother 1994; 38: 2651-2654.
25. Bébéar CM, Renaudin H, Aydin MD, Chantot JF, Bébéar C. In-vitro activity of ketolides against mycoplasmas. J Antimicrob Chemother 1997; 39: 669-670.
26. Del Guidice RA, Tully JG, Rose DL, Cole RM. Mycoplasma pirum sp. nov., a terminal structure mollcute from cell cultures. Int J Syst Bacteriol 1985; 35: 285-291.
27. Tully JG, Rose DL, Baseman JB, Dallo SE, Lazzell AL, Davis CP. Mycoplasma pneumoniae and Mycoplasma genitalium mixture in synovial fluid isolate. J Clin Microbiol 1995; 33: 1851-1855.
28. Jensen JS, Hansen HT, Lind K. Isolation of Mycoplasma genitalium from the male urethra. J Clin Microbiol 1996; 34: 286-291.
29. Clyde WA. Mycoplasma species identification based upon growth inhibition by specific antisera. J Immunol 1964; 92: 958-965.
30. Tanner AC, Wu CC. Adaptation of the Sensititre broth microdilution technique to antimicrobial susceptibility testing of Mycoplasma gallisepticum. Avian Dis 1992; 36: 714-717.
31. Hannan PCT, O'Hanlon PJ, Rogers NH. In vitro evaluation of various qiunolone antibacterial agents against veterinary mycoplasmas and porcine respiratory bacterial pathogens. Rev Vet Sci 1989; 46: 202-211.
32. Sehmitt K, Dänbener W, Bitter-Suermann D, Hadding U. A safe and efficient methods for elimination of cell culture mycoplasmas using ciprofloxacin. J Immunol Methods 1988; 109: 17-25.
33. Eaton MD, Meicklejohn G, van Herick W. Studies on the etiology of primary atypical pneumonia. A filterable agent transmissable to cotton rats, hamsters, and chick embryos. J Exp Med 1944; 79: 649-668.
34. Eaton MD, Liu C. Studies on sensitivity to streptomycin of the atypical pneumonia agent. J Bacteriol 1957; 74: 784 787.
35. Kubota H. Development of resistance to and dependence on streptomycin in Mycoplasma pneumoniae in vitro. Jpn J Microbiol 1974; 18: 157-163.
36. Niitu Y, Kubota H, Hasegawa S, Komatsu S, Horikawa M, Suetake T. Susceptibility of Mycoplasma pneumoniae to antibiotics in vitro. Jpn J Microbiol 1974; 18: 149-155.
37. Philips I, Shannon K. Aminoglycoside resistance. Br Med Bull 1984; 40: 28-35.
38. Hannan PCT. Observations on the possible origin of Mycoplasma fermentans incognitus strain based on antibiotic sensitivity tests. J Antimicrob Chemother 1997; 39: 25-30
39. Hannan PCT, Kearns AM, Sisson PR, Freeman R. Differentiation of strains of M. fermentans from various sources by pyrolysis mass spectrometry. J Med Microbiol 1997; 46: 348-353.